研究单位：[1]Guangdong Raynovent Biotech Co.,Ltd[2]The first People hospital of Yunnan Province Kunming,Yunnan,China[3]Tianjin Medical University General Hospital Tianjin,Tianjin,China[4]The First Affiliated Hospital,Zhejiang University School of Medicine Hangzhou,Zhejiang,China[5]Ruian People's Hospital Ruian,Zhejiang,China[6]Shanxi Bethune Hospital Taiyuan,Shanxi,China[7]Shanghai East Hospital Shanghai,Shanghai,China[8]PKUCare luzhong Hospital Zibo,Shandong,China
研究目的：
This is a multi-center, randomized, double-blind, placebo-controlled, and active controlled clinical trial to assess the efficacy and safety of ZSP1273 tablets in the treatment of Acute Uncomplicated influenza A.
